Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;107(5):486-490.
doi: 10.1257/aer.p20171086.

Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs

Affiliations

Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs

Margaret Kyle et al. Am Econ Rev. 2017 May.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diffusion: US and Australia
Figure 2
Figure 2
Diffusion: US and Canada
Figure 3
Figure 3
Diffusion: US and Switzerland
Figure 4
Figure 4
Diffusion: US and UK

References

    1. Chandra Amitabh, Skinner Jonathan. Technology Growth and Expenditure Growth in Health Care. Journal of Economic Literature. 2012;50(3):645–680.
    1. Cockburn Iain, Lanjouw Jean, Schankerman Mark. Global Diffusion of New Drugs: The Role of Patent Policy, Price Controls and Institutions. American Economic Review. 2016;106(1):136–164. - PubMed
    1. Danzon Patricia M, Wang Richard, Wang Liang. The Impact of Price Regulation on the Launch Delay of New Drugs – Evidence from Twenty-five Major Markets in the 1990s. Health Economics. 2005;14:269–292. - PubMed
    1. Garber Alan, Skinner Jonathan. Is American Health Care Uniquely Inefficient? Journal of Economic Perspectives. 2008;22(4):27–50. - PMC - PubMed
    1. Kyle Margaret. Pharmaceutical Price Controls and Entry Strategies. Review of Economics and Statistics. 2007;89(1):88–99.

Substances

LinkOut - more resources